郑志华;伍俊妍;曾英彤;王若伦;王景浩;黎小妍;李健;陈文瑛;王勇;
ZHENG Zhihua;WU Junyan;ZENG Yingtong;WANG Ruolun;WANG Jinghao;LI Xiaoyan;LI Jian;CHEN Wenying;WANG Yong;Guangdong Pharmaceutical Association;Sun Yat-sen Memorial Hospital,Sun Yat-sen University;Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences;Second Affiliated Hospital of Guangzhou Medical University;The First Affiliated Hospital,Jinan University;The Sixth Affiliated Hospital,Sun Yat-sen University;General Hospital of Southern Theatre Command of PLA;The Third Affiliat

• 1:广东省药学会
• 2:中山大学孙逸仙纪念医院
• 3:广东省人民医院广东省医学科学院
• 4:广州医科大学附属第二医院

摘要(Abstract)：

由于外科医生的关注焦点为外科手术,而药物治疗也是围手术期的重要治疗手段,因此,如果药师能管理好外科的药物治疗,可让外科治疗获取更好的治疗效果。广东省药学会于2015年底在中国首先提出"外科药师"的概念,并于2018年9月呼吁设立"外科药师"岗位。广东省药学会提出的"外科药师"工作内容与美国卫生系统药师协会(American Society of HealthSystem Pharmacists)的不同。目前国内的一些医院已经设立了该岗位。
Most surgeons are adept at surgical procedures rather than medication therapy. If pharmacists take care of the medication therapy,surgeons can pay more attention to surgical procedures. The Guangdong Pharmaceutical Association put forward the concept of surgical pharmacist first and applied to create this position in China,which is unlike that of American Society of Health-System Pharmacists. Now some hospitals have established the positions of surgical pharmacist in China.

关键词(KeyWords)： 外科药师;临床药师;围手术期;合作药物治疗管理
surgical pharmacist;clinical pharmacy;perioperative period;Collaborative Drug Therapy Management(CDTM)

Abstract:

Keywords:

基金项目(Foundation):

作者(Author): 郑志华;伍俊妍;曾英彤;王若伦;王景浩;黎小妍;李健;陈文瑛;王勇;
ZHENG Zhihua;WU Junyan;ZENG Yingtong;WANG Ruolun;WANG Jinghao;LI Xiaoyan;LI Jian;CHEN Wenying;WANG Yong;Guangdong Pharmaceutical Association;Sun Yat-sen Memorial Hospital,Sun Yat-sen University;Guangdong Provincial People's Hospital,Guangdong Academy of Medical Sciences;Second Affiliated Hospital of Guangzhou Medical University;The First Affiliated Hospital,Jinan University;The Sixth Affiliated Hospital,Sun Yat-sen University;General Hospital of Southern Theatre Command of PLA;The Third Affiliat

Email:

DOI:

参考文献(References)：

• [1]Zheng Z,Wu J,Zeng Y,et al.Creating the position of surgical pharmacist in China[J].Eur J Hosp Pharm epub ahead of print:27-Feb-2020.Doi:10.1136/ejhpharm-2020-002238．
• [2]李桂荣，裴祺，樊萍，等．审方药师医嘱审核干预对我院胃肠肿瘤外科不合理用药的影响分析[J]．新疆医学，2016,46(5):553-556．
• [3]闫美兴，柳波，张七妹．临床药师医嘱审核干预对我院普外科不合理静脉用药的影响分析[J]．中国药房，2011,22(22):2110-2112．
• [4]徐加佳，孙翠萍，吴青．基于FMEA的PIVAS不合理医嘱风险评估和管理[J]．中国现代应用药学，2018,35(10):1564-1568．
• [5]Axelsen T B,Nielsen K T,Jepsen H,et al.Prescription and administration of medicine in a surgical department.Clinical pharmacists increase the safety of medical treatment of surgical patients[J].Eur JHosp Pharm,2012,19(2):231-232．
• [6]郑志华，王勇．广东省药学门诊工作的推进[J]．今日药学，2018,28(8):576．
• [7]Zheng Z,Zeng Y,Wu J.Rise of pharmacist-managed clinics in Guangdong Province,China[J].Eur J Hosp Pharm,2018,25(5):290．
• [8]American Society of Health-System Pharmacists.ASHP guidelines on perioperative pharmacy services[J].Am J Health-Syst Pharm,2019(76):903-920．
• [9]郑志华，黄红兵，王景浩，等．推动“处方精简”工作在我国的开展[J]．今日药学，2019,29(6):431-432．
• [10]Zheng Z,Huang H,Wang Y,et al.Spread of the idea of‘deprescribingin China[J].Eur J Hosp Pharm,2019,26(4):239-240．
• [11]Roberts S,Gainsbrugh R.Medication therapy management and collaborative drug therapy management[J].J Manag Care Pharm,2010,16(1):67-69．
• [12]广东省药学会．药师与医师抗栓治疗协议推荐文本[J]．今日药学，2017,27(4):217-224．
• [13]广东省药学会．临床药师术后疼痛管理指引[J]．今日药学，2019,29(4):217-227．
• [14]广东省药学会．肠内营养临床药学共识(第二版)[J]．今日药学，2017,27(6):361-371．
• [15]广东省药学会．肠外营养临床药学共识(第二版)[J]．今日药学，2017,27(5):289-303．
• [16]广东省药学会．围手术期血糖管理医-药专家共识[J]．今日药学，2018,28(2):73-83．
• [17]广东省药学会．围手术期血压管理医-药专家共识[J]．今日药学，2019,29(5):289-303．
• [18]广东省药学会．加速康复外科围手术期药物治疗管理医药专家共识[J/OL]．今日药学[2020-02-06].http://kns.cnki.net/kcms/detail/44.1650.R.20191231.1650.002.html．
• [19]赵文霞，伍俊妍，郑志华．外科药师参与骨科住院患者的药学实践[J]．今日药学，2019,29(9):406-409．
• [20]卢钧雄，刘瑜，王若伦．临床药师在肝胆外科术后急性疼痛管理中的作用及工作实践[J]．中国医院药学杂志，2019,39(20):2099-2102,2106.